Nucleoside Analog Antiviral
28 drugs across 14 manufacturers|27 Generic,1 Brand
The Nucleoside Analog Antiviral class contains 28 NDCs from 14 manufacturers (27 generic, 1 brand), at an average NADAC of $5.47 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
28
27G / 1B
Manufacturers
14
Avg $5.4707/unit
Avg 7d Change
-3.19%
Across 21 drugs with changes
7d Activity
of 28 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Frequently Asked Questions
How many drugs are in the Nucleoside Analog Antiviral class?
The Nucleoside Analog Antiviral class contains 28 NDCs from 14 manufacturers — 27 generic and 1 brand product.
What is the average price of Nucleoside Analog Antiviral drugs?
The average NADAC for the Nucleoside Analog Antiviral class is $5.4707 per unit across 28 NDCs.
Is generic cheaper than brand in the Nucleoside Analog Antiviral class?
The average generic NADAC in this class is $2.2911 per unit, versus $91.3192 for brand — generic is about 97% cheaper on average.
Which manufacturers make Nucleoside Analog Antiviral drugs?
14 manufacturers make drugs in the Nucleoside Analog Antiviral class. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (8), Major Pharmaceuticals (3), American Health Packaging (3), Ajanta Pharma USA Inc. (2), Camber Pharmaceuticals Inc. (2).
How has Nucleoside Analog Antiviral pricing changed recently?
Over the past 7 days, 12 NDCs in this class rose and 9 fell, with a class-wide average change of -3.2%.
Manufacturer Breakdown
14 manufacturers producing drugs in this therapeutic class(2 pricing outliers)
and 2 more manufacturers